The Hyderabad-based drug firm noted that it has made good progress in the R&D field for planned submission batches for complex injectables to be filed in the current financial year.
Read More
The company got approval from the capital market regulator SEBI on October 29 for the initial public offering. It will raise Rs 150 crore fresh capital, while 1.32 crore shares will be on offer for sale from promoters and a private equity investor. There is no company in India into PCR and cell/tissue culture space.
Read More
We need to change the way we pay for our healthcare and bridge the gap between what our health insurance pays for and our family’s actual healthcare expenses.
Read More
J&J said in a filing with the U.S. Securities and Exchange Commission on Friday that it reached a settlement in principle in September to resolve 'substantially all' of the roughly 9,000 cases that the New Brunswick, New Jersey-based drugmaker faced over Risperdal.
Read More
The weaker-than-expected growth reported by the Commerce Department on Thursday also reflected decreasing pandemic relief money from the government to businesses, state and local governments as well as households.
Read More
Revenue from operations for the second quarter of FY22 stood at Rs 380.13 crore as against Rs 340.32 crore in the year-ago period.
Read More
MoU has been inked between IIT Kanpur and JK Cement.
Read More
The company is about to invest $15 million in the first phase.
Read More
